> Detailanzeige

Reetz, Kathrin [Verfasser:in]; Rodríguez-Labrada, Roberto [Verfasser:in]; Auburger, Georg [Verfasser:in]; Velázquez-Pérez, Luis [Verfasser:in]; Dogan, Imis [Verfasser:in]; Mirzazade, Shahram [Verfasser:in]; Romanzetti, Sandro [Verfasser:in]; Schulz, Jörg B. [Verfasser:in]; Cruz-Rivas, Edilia M. [Verfasser:in]; Alvarez-Cuesta, Jose A. [Verfasser:in]; Aguilera Rodríguez, Raul [Verfasser:in]; Gonzalez Zaldivar, Yanetza [Verfasser:in]

Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2
  • Beteiligte: Reetz, Kathrin [Verfasser:in]; Rodríguez-Labrada, Roberto [Verfasser:in]; Auburger, Georg [Verfasser:in]; Velázquez-Pérez, Luis [Verfasser:in]; Dogan, Imis [Verfasser:in]; Mirzazade, Shahram [Verfasser:in]; Romanzetti, Sandro [Verfasser:in]; Schulz, Jörg B. [Verfasser:in]; Cruz-Rivas, Edilia M. [Verfasser:in]; Alvarez-Cuesta, Jose A. [Verfasser:in]; Aguilera Rodríguez, Raul [Verfasser:in]; Gonzalez Zaldivar, Yanetza [Verfasser:in]
  • Erschienen: Wiley, 2018
  • Erschienen in: Annals of Clinical and Translational Neurology 5(2), 128 - 137 (2018). doi:10.1002/acn3.504
  • Sprache: Englisch
  • DOI: https://doi.org/10.1002/acn3.504
  • ISSN: 2328-9503
  • Entstehung:
  • Anmerkungen: Diese Datenquelle enthält auch Bestandsnachweise, die nicht zu einem Volltext führen.
  • Beschreibung: ObjectiveSpinocerebellar ataxia type 2 (SCA2) is an autosomal dominantly inherited neurodegenerative disease mainly affecting the cerebellum and brainstem. In this Cuban‐German research collaboration, we aimed to characterize atrophy patterns and associations with clinical measures in preclinical and manifest SCA2.MethodsIn this study, 16 nonmanifest SCA2 mutation carriers, 26 manifest patients with SCA2, and 18 healthy control subjects underwent magnetic resonance imaging, as well as genetic and clinical characterization including assessment of ataxia (Scale for the Assessment and Rating of Ataxia) and saccade velocity in Cuba were enrolled. Semiautomated quantitative volumetry of the cerebellum and brainstem, subdivided into the medulla oblongata, the pontine brainstem, and mesencephalon was performed. Additionally, the anteroposterior diameter of the pontine brainstem was measured.ResultsAnalysis of volumetric data revealed degeneration of the cerebellum and brainstem, in particular of pontine volumes and the anteroposterior diameter of the pons, in both manifest SCA2 patients and individuals at risk for SCA2 compared to controls. Comparing patients with nonataxic preclinical SCA2 mutation carriers, we found more pronounced reductions of the pontine brainstem and cerebellum in manifest SCA2. Volumetric data further showed associations with CAG repeat length and predicted age of onset in preclinical SCA2 individuals, and by trend with ataxia signs in patients. Although saccade velocity was associated with reduction in the pontine brainstem in preclinical and manifest SCA2, reduced ability to suppress interfering stimuli measured by the Stroop task was related to cerebellar volume loss in patients.
  • Zugangsstatus: Freier Zugang